Luni Emdad

6.9k total citations
120 papers, 5.4k citations indexed

About

Luni Emdad is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Luni Emdad has authored 120 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 48 papers in Oncology and 26 papers in Pathology and Forensic Medicine. Recurrent topics in Luni Emdad's work include Cancer Mechanisms and Therapy (25 papers), Virus-based gene therapy research (21 papers) and Axon Guidance and Neuronal Signaling (17 papers). Luni Emdad is often cited by papers focused on Cancer Mechanisms and Therapy (25 papers), Virus-based gene therapy research (21 papers) and Axon Guidance and Neuronal Signaling (17 papers). Luni Emdad collaborates with scholars based in United States, India and Canada. Luni Emdad's co-authors include Paul B. Fisher, Devanand Sarkar, Swadesh K. Das, Praveen Bhoopathi, Seok‐Geun Lee, Sarmistha Talukdar, Xiang‐Yang Wang, Anjan K. Pradhan, Mitchell E. Menezes and Zao-zhong Su and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Luni Emdad

120 papers receiving 5.4k citations

Peers

Luni Emdad

ONCOL

PFM

IMMUN

Kevin M. Haigis United States

Xu Tao China

JC Reed United States

Elizabeth Yang United States

Kazuya Shinmura Japan

Román Herrera United States

Li Lan China

Lindsey D. Mayo United States

Amardeep S. Dhillon Australia

Franca Stivala Italy

Kevin M. Haigis United States

Luni Emdad

3.9k ×1.2

2.5k ×1.4

ONCOL

899 ×0.6

PFM

1.0k ×1.1

609 ×0.7

IMMUN

Citations per year, relative to Luni Emdad Luni Emdad (= 1×) peers Kevin M. Haigis

Countries citing papers authored by Luni Emdad

Since Specialization

Citations

This map shows the geographic impact of Luni Emdad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luni Emdad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luni Emdad more than expected).

Fields of papers citing papers by Luni Emdad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luni Emdad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luni Emdad. The network helps show where Luni Emdad may publish in the future.

Co-authorship network of co-authors of Luni Emdad

This figure shows the co-authorship network connecting the top 25 collaborators of Luni Emdad. A scholar is included among the top collaborators of Luni Emdad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luni Emdad. Luni Emdad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mannangatti, Padmanabhan, Praveen Bhoopathi, Amit Kumar, et al.. (2024). Precision medicine focus on the central nervous system: Non-invasive therapeutic agent delivery with focused ultrasound and microbubbles. Advances in cancer research. 164. 191–240. 1 indexed citations

Maji, Santanu, Amit Kumar, Praveen Bhoopathi, et al.. (2023). Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Molecular Cancer Therapeutics. 22(10). 1115–1127. 4 indexed citations

Talukdar, Sarmistha, Luni Emdad, Rajan Gogna, Swadesh K. Das, & Paul B. Fisher. (2021). Metabolic control of cancer progression as novel targets for therapy. Advances in cancer research. 152. 103–177. 5 indexed citations

Das, Swadesh K., Timothy P. Kegelman, Anjan K. Pradhan, et al.. (2019). Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor. Molecular Cancer Therapeutics. 18(11). 1997–2007. 22 indexed citations

Pradhan, Anjan K., Praveen Bhoopathi, Sarmistha Talukdar, et al.. (2018). Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway. Molecular Cancer Therapeutics. 17(9). 1951–1960. 21 indexed citations

Das, Swadesh K., Anjan K. Pradhan, Praveen Bhoopathi, et al.. (2018). The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. Cancer Research. 78(11). 2852–2863. 42 indexed citations

Pradhan, Anjan K., Sarmistha Talukdar, Praveen Bhoopathi, et al.. (2016). mda-7/IL-24 Mediates Cancer Cell–Specific Death via Regulation of miR-221 and the Beclin-1 Axis. Cancer Research. 77(4). 949–959. 49 indexed citations

Bhoopathi, Praveen, Nathaniel Lee, Anjan K. Pradhan, et al.. (2016). mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM. Cancer Research. 76(12). 3572–3582. 31 indexed citations

Hu, Bin, Luni Emdad, Timothy P. Kegelman, et al.. (2016). Astrocyte Elevated Gene-1 Regulates β-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal. Molecular Cancer Research. 15(2). 225–233. 24 indexed citations

10.

Robertson, Chadia L., Jyoti Srivastava, Ayesha Siddiq, et al.. (2014). Genetic Deletion of AEG-1 Prevents Hepatocarcinogenesis. Cancer Research. 74(21). 6184–6193. 44 indexed citations

11.

Hu, Bin, Luni Emdad, Manny D. Bacolod, et al.. (2014). Astrocyte Elevated Gene-1 Interacts with Akt Isoform 2 to Control Glioma Growth, Survival, and Pathogenesis. Cancer Research. 74(24). 7321–7332. 55 indexed citations

12.

Bhoopathi, Praveen, Bridget A. Quinn, Qin Gui, et al.. (2014). Pancreatic Cancer–Specific Cell Death Induced In Vivo by Cytoplasmic-Delivered Polyinosine–Polycytidylic Acid. Cancer Research. 74(21). 6224–6235. 34 indexed citations

13.

Talukdar, Sarmistha, Luni Emdad, Swadesh K. Das, Devanand Sarkar, & Paul B. Fisher. (2014). Noninvasive approaches for detecting and monitoring bladder cancer. Expert Review of Anticancer Therapy. 15(3). 283–294. 8 indexed citations

14.

Dash, Rupesh, Praveen Bhoopathi, Swadesh K. Das, et al.. (2013). Novel Mechanism of MDA-7/IL-24 Cancer-Specific Apoptosis through SARI Induction. Cancer Research. 74(2). 563–574. 42 indexed citations

15.

Dasgupta, Santanu, Mitchell E. Menezes, Swadesh K. Das, et al.. (2013). Novel Role of MDA-9/Syntenin in Regulating Urothelial Cell Proliferation by Modulating EGFR Signaling. Clinical Cancer Research. 19(17). 4621–4633. 53 indexed citations

16.

Das, Swadesh K., Sujit K. Bhutia, Belal Azab, et al.. (2012). MDA-9/Syntenin and IGFBP-2 Promote Angiogenesis in Human Melanoma. Cancer Research. 73(2). 844–854. 79 indexed citations

17.

Emdad, Luni, et al.. (2011). Efficient Differentiation of Human Embryonic and Induced Pluripotent Stem Cells into Functional Astrocytes. Stem Cells and Development. 21(3). 404–410. 109 indexed citations

18.

Emdad, Luni, Devanand Sarkar, Seok‐Geun Lee, et al.. (2010). Astrocyte Elevated Gene-1: A Novel Target for Human Glioma Therapy. Molecular Cancer Therapeutics. 9(1). 79–88. 87 indexed citations

19.

Park, Margaret A., Teneille Walker, Aditi Pandya Martin, et al.. (2009). MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism. Molecular Cancer Therapeutics. 8(5). 1280–1291. 40 indexed citations

20.

Takeuchi, Susumu, Mahmud Uzzaman, Luni Emdad, et al.. (2001). Internalization of Cx43 gap junctions in hypertrophied rat ventricular myocytes. 45(2). 97–99. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact